AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 325.38M | 320.17M | 313.73M | 307.31M | 300.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 325.38M | 320.17M | 313.73M | 307.31M | 300.72M |
| Cost of Revenue | 145.50M | 145.28M | 143.39M | 139.59M | 137.88M |
| Gross Profit | 179.88M | 174.89M | 170.34M | 167.72M | 162.84M |
| SG&A Expenses | 159.44M | 157.61M | 152.84M | 150.62M | 149.69M |
| Depreciation & Amortization | 10.76M | 10.68M | 10.55M | 10.48M | 10.40M |
| Other Operating Expenses | 138.00K | 138.00K | -493.00K | -493.00K | -493.00K |
| Total Operating Expenses | 346.27M | 342.64M | 333.68M | 327.48M | 323.47M |
| Operating Income | -20.89M | -22.47M | -19.96M | -20.18M | -22.76M |
| Income Before Tax | -32.76M | -36.30M | -31.38M | -27.71M | -32.21M |
| Income Tax Expenses | 178.00K | 442.00K | 12.00K | -2.00K | -107.00K |
| Earnings from Continuing Operations | -32.94 | -36.74 | -31.39 | -27.71 | -32.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.94M | -36.74M | -31.39M | -27.71M | -32.10M |
| EBIT | -20.89M | -22.47M | -19.96M | -20.18M | -22.76M |
| EBITDA | 1.24M | 118.00K | -236.00K | 273.00K | -1.19M |
| EPS Basic | -0.79 | -0.89 | -0.76 | -0.67 | -0.78 |
| Normalized Basic EPS | -0.26 | -0.28 | -0.24 | -0.23 | -0.27 |
| EPS Diluted | -0.79 | -0.89 | -0.76 | -0.68 | -0.79 |
| Normalized Diluted EPS | -0.26 | -0.28 | -0.24 | -0.23 | -0.27 |
| Average Basic Shares Outstanding | 166.86M | 166.01M | 165.30M | 164.55M | 163.93M |
| Average Diluted Shares Outstanding | 166.86M | 166.01M | 165.30M | 164.55M | 163.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |